Pyrimidine derivatives for treatment of hyperproliferative disorders

22a Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R, G, G′, and G″ represent substituent groups and Rrepresents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and metho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dixon, Julie A, Nagarathnam, Dhanapalan, Zhang, Lei, Wang, Chunguang, Yi, Lin, Chen, Yuanwei, Chen, Jianqing, Bear, Brian R, Brands, Michael, Hillisch, Alexander, Bierer, Donald, Wang, Ming, Fu, Wenlang, Hentemann, Martin F, Bullion, Ann-Marie, Patel, Manoj
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Dixon, Julie A
Nagarathnam, Dhanapalan
Zhang, Lei
Wang, Chunguang
Yi, Lin
Chen, Yuanwei
Chen, Jianqing
Bear, Brian R
Brands, Michael
Hillisch, Alexander
Bierer, Donald
Wang, Ming
Fu, Wenlang
Hentemann, Martin F
Bullion, Ann-Marie
Patel, Manoj
description 22a Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R, G, G′, and G″ represent substituent groups and Rrepresents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and methods of using these compounds in treatment of hyperproliferative diseases such as cancer are also disclosed and claimed.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07678804</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07678804</sourcerecordid><originalsourceid>FETCH-uspatents_grants_076788043</originalsourceid><addsrcrecordid>eNrjZHAJqCzKzM1MycxLVUhJLcosSyzJLEstVkjLL1IoKUpNLMlNzStRyE9TyKgsSC0qKMrPyUxLLQIrUkjJLM4vAmoq5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJUADiuPTixJBlIG5mbmFhYGJMRFKABHmNQw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrimidine derivatives for treatment of hyperproliferative disorders</title><source>USPTO Issued Patents</source><creator>Dixon, Julie A ; Nagarathnam, Dhanapalan ; Zhang, Lei ; Wang, Chunguang ; Yi, Lin ; Chen, Yuanwei ; Chen, Jianqing ; Bear, Brian R ; Brands, Michael ; Hillisch, Alexander ; Bierer, Donald ; Wang, Ming ; Fu, Wenlang ; Hentemann, Martin F ; Bullion, Ann-Marie ; Patel, Manoj</creator><creatorcontrib>Dixon, Julie A ; Nagarathnam, Dhanapalan ; Zhang, Lei ; Wang, Chunguang ; Yi, Lin ; Chen, Yuanwei ; Chen, Jianqing ; Bear, Brian R ; Brands, Michael ; Hillisch, Alexander ; Bierer, Donald ; Wang, Ming ; Fu, Wenlang ; Hentemann, Martin F ; Bullion, Ann-Marie ; Patel, Manoj ; Bayer Healthcare LLC</creatorcontrib><description>22a Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R, G, G′, and G″ represent substituent groups and Rrepresents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and methods of using these compounds in treatment of hyperproliferative diseases such as cancer are also disclosed and claimed.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7678804$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7678804$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dixon, Julie A</creatorcontrib><creatorcontrib>Nagarathnam, Dhanapalan</creatorcontrib><creatorcontrib>Zhang, Lei</creatorcontrib><creatorcontrib>Wang, Chunguang</creatorcontrib><creatorcontrib>Yi, Lin</creatorcontrib><creatorcontrib>Chen, Yuanwei</creatorcontrib><creatorcontrib>Chen, Jianqing</creatorcontrib><creatorcontrib>Bear, Brian R</creatorcontrib><creatorcontrib>Brands, Michael</creatorcontrib><creatorcontrib>Hillisch, Alexander</creatorcontrib><creatorcontrib>Bierer, Donald</creatorcontrib><creatorcontrib>Wang, Ming</creatorcontrib><creatorcontrib>Fu, Wenlang</creatorcontrib><creatorcontrib>Hentemann, Martin F</creatorcontrib><creatorcontrib>Bullion, Ann-Marie</creatorcontrib><creatorcontrib>Patel, Manoj</creatorcontrib><creatorcontrib>Bayer Healthcare LLC</creatorcontrib><title>Pyrimidine derivatives for treatment of hyperproliferative disorders</title><description>22a Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R, G, G′, and G″ represent substituent groups and Rrepresents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and methods of using these compounds in treatment of hyperproliferative diseases such as cancer are also disclosed and claimed.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZHAJqCzKzM1MycxLVUhJLcosSyzJLEstVkjLL1IoKUpNLMlNzStRyE9TyKgsSC0qKMrPyUxLLQIrUkjJLM4vAmoq5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJUADiuPTixJBlIG5mbmFhYGJMRFKABHmNQw</recordid><startdate>20100316</startdate><enddate>20100316</enddate><creator>Dixon, Julie A</creator><creator>Nagarathnam, Dhanapalan</creator><creator>Zhang, Lei</creator><creator>Wang, Chunguang</creator><creator>Yi, Lin</creator><creator>Chen, Yuanwei</creator><creator>Chen, Jianqing</creator><creator>Bear, Brian R</creator><creator>Brands, Michael</creator><creator>Hillisch, Alexander</creator><creator>Bierer, Donald</creator><creator>Wang, Ming</creator><creator>Fu, Wenlang</creator><creator>Hentemann, Martin F</creator><creator>Bullion, Ann-Marie</creator><creator>Patel, Manoj</creator><scope>EFH</scope></search><sort><creationdate>20100316</creationdate><title>Pyrimidine derivatives for treatment of hyperproliferative disorders</title><author>Dixon, Julie A ; Nagarathnam, Dhanapalan ; Zhang, Lei ; Wang, Chunguang ; Yi, Lin ; Chen, Yuanwei ; Chen, Jianqing ; Bear, Brian R ; Brands, Michael ; Hillisch, Alexander ; Bierer, Donald ; Wang, Ming ; Fu, Wenlang ; Hentemann, Martin F ; Bullion, Ann-Marie ; Patel, Manoj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_076788043</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Dixon, Julie A</creatorcontrib><creatorcontrib>Nagarathnam, Dhanapalan</creatorcontrib><creatorcontrib>Zhang, Lei</creatorcontrib><creatorcontrib>Wang, Chunguang</creatorcontrib><creatorcontrib>Yi, Lin</creatorcontrib><creatorcontrib>Chen, Yuanwei</creatorcontrib><creatorcontrib>Chen, Jianqing</creatorcontrib><creatorcontrib>Bear, Brian R</creatorcontrib><creatorcontrib>Brands, Michael</creatorcontrib><creatorcontrib>Hillisch, Alexander</creatorcontrib><creatorcontrib>Bierer, Donald</creatorcontrib><creatorcontrib>Wang, Ming</creatorcontrib><creatorcontrib>Fu, Wenlang</creatorcontrib><creatorcontrib>Hentemann, Martin F</creatorcontrib><creatorcontrib>Bullion, Ann-Marie</creatorcontrib><creatorcontrib>Patel, Manoj</creatorcontrib><creatorcontrib>Bayer Healthcare LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dixon, Julie A</au><au>Nagarathnam, Dhanapalan</au><au>Zhang, Lei</au><au>Wang, Chunguang</au><au>Yi, Lin</au><au>Chen, Yuanwei</au><au>Chen, Jianqing</au><au>Bear, Brian R</au><au>Brands, Michael</au><au>Hillisch, Alexander</au><au>Bierer, Donald</au><au>Wang, Ming</au><au>Fu, Wenlang</au><au>Hentemann, Martin F</au><au>Bullion, Ann-Marie</au><au>Patel, Manoj</au><aucorp>Bayer Healthcare LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrimidine derivatives for treatment of hyperproliferative disorders</title><date>2010-03-16</date><risdate>2010</risdate><abstract>22a Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R, G, G′, and G″ represent substituent groups and Rrepresents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and methods of using these compounds in treatment of hyperproliferative diseases such as cancer are also disclosed and claimed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07678804
source USPTO Issued Patents
title Pyrimidine derivatives for treatment of hyperproliferative disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A36%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dixon,%20Julie%20A&rft.aucorp=Bayer%20Healthcare%20LLC&rft.date=2010-03-16&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07678804%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true